APOB and metabolic syndrome: Dyslipidemia plays a major role on the increased risk of cardiovascular events, CVD-related, and all-cause mortality due to an increase in atherogenic lipoproteins such as Apo B that may become entrapped within the subendothelial space and undergo oxidation and scavenging by arterial macrophages, resulting in endothelial dysfunction and formation of foam cells, fatty streaks, and atherosclerotic plaque.